Quant Healthcare Fund - Growth - Regular Plan

Other Plans and Options
  • 0.58 %Nav, as on 28-03-2025

  • Previous Nav

  • Net Change on 28-03-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The investment objective of the scheme is to seek long term capital appreciation by investing in equity/equity related instruments of companies from the healthcare sector. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A
Nifty India Consumption - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Nippon India Pharma Fund-Growth Plan-Growth Jun 05, 2004 13.64 18.57 28.43 1.82 7,637.04
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option Jul 13, 2018 21.83 22.88 31.69 1.94 4,611.47
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH Jul 14, 1999 20.79 22.99 30.40 1.95 3,312.89
DSP Healthcare Fund - Regular Plan - Growth Nov 30, 2018 15.61 19.92 29.41 1.93 2,950.74
Mirae Asset Healthcare Fund -Regular Growth Jul 02, 2018 18.20 17.66 28.89 1.96 2,441.13

Fund Holdings as on 28-February-2025

  • Divi's Laboratories Limited

  • RPG Life Sciences Limited

  • Aster DM Healthcare Limited

  • Zydus Lifesciences Limited

  • IPCA Laboratories Ltd

  • Torrent Pharmaceuticals Ltd

  • Reliance Industries Limited

  • Aurobindo Pharma Limited

  • Alivus Life Sciences

  • Zydus Wellness Ltd

  • Sequent Scientific Limited

  • Pfizer Ltd

  • HFCL Limited

  • SMS Pharmaceuticals Limited

  • 91 Days Treasury Bill 24-Apr-2025

  • Suraksha Diagnostic Limited

  • Dr. Reddy's Laboratories Limited 27/03/2025

  • TREPS 03-Mar-2025 DEPO 10

  • Zydus Lifesciences Limited 27/03/2025

  • NCA-NET CURRENT ASSETS

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Refineries

  • Consumer Food

  • Telecom-Infrastructure

  • Miscellaneous

View More

Fund Manager

  • Cash

  • Derivatives

  • Equity

  • SOV

View More

About Quant Healthcare Fund

Scheme Analysis

Quant Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to Quant Mutual Fund. It was launched on 17-Jul-2023 and currently has an AUM of ₹347.52 crore. Quant Healthcare Fund is benchmarked against NIFTY 50 - TRI as primary index and Nifty India Consumption - TRI as secondary index.

The NAV of Quant Healthcare Fund ended up ₹0.08(0.58%)yesterday to ₹14.0993.

Among its top 3 holdings the fund has exposure to Divi's Laboratories Limited, and

The Quant Healthcare Fund is managed by Ankit Pande and Sandeep Tandon.

Fund House Contact

6th Floor, Sea Breeze Building, Appa Saheb Marathe Marg, Prabhadevi, Mumbai - 400025

022-6295 5000
help@quant.in
022-6295 5000